These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38327847)

  • 1. Longitudinal faster anxiety progression of
    Sang S; Ba Y; Yang N
    Front Neurosci; 2024; 18():1353759. PubMed ID: 38327847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study.
    Simuni T; Uribe L; Cho HR; Caspell-Garcia C; Coffey CS; Siderowf A; Trojanowski JQ; Shaw LM; Seibyl J; Singleton A; Toga AW; Galasko D; Foroud T; Tosun D; Poston K; Weintraub D; Mollenhauer B; Tanner CM; Kieburtz K; Chahine LM; Reimer A; Hutten SJ; Bressman S; Marek K;
    Lancet Neurol; 2020 Jan; 19(1):71-80. PubMed ID: 31678032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of GBA variants on longitudinal freezing of gait progression in early Parkinson's disease.
    Yang N; Sang S; Peng T; Hu W; Wang J; Bai R; Lu H
    J Neurol; 2023 May; 270(5):2756-2764. PubMed ID: 36790548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of GBA Mutations and the E326K Polymorphism With Motor and Cognitive Progression in Parkinson Disease.
    Davis MY; Johnson CO; Leverenz JB; Weintraub D; Trojanowski JQ; Chen-Plotkin A; Van Deerlin VM; Quinn JF; Chung KA; Peterson-Hiller AL; Rosenthal LS; Dawson TM; Albert MS; Goldman JG; Stebbins GT; Bernard B; Wszolek ZK; Ross OA; Dickson DW; Eidelberg D; Mattis PJ; Niethammer M; Yearout D; Hu SC; Cholerton BA; Smith M; Mata IF; Montine TJ; Edwards KL; Zabetian CP
    JAMA Neurol; 2016 Oct; 73(10):1217-1224. PubMed ID: 27571329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and Dopamine Transporter Imaging Characteristics of Leucine Rich Repeat Kinase 2 (LRRK2) and Glucosylceramidase Beta (GBA) Parkinson's Disease Participants in the Parkinson's Progression Markers Initiative: A Cross-Sectional Study.
    Simuni T; Brumm MC; Uribe L; Caspell-Garcia C; Coffey CS; Siderowf A; Alcalay RN; Trojanowski JQ; Shaw LM; Seibyl J; Singleton A; Toga AW; Galasko D; Foroud T; Nudelman K; Tosun-Turgut D; Poston K; Weintraub D; Mollenhauer B; Tanner CM; Kieburtz K; Chahine LM; Reimer A; Hutten S; Bressman S; Marek K;
    Mov Disord; 2020 May; 35(5):833-844. PubMed ID: 32073681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The longitudinal progression of autonomic dysfunction in Parkinson's disease: A 7-year study.
    Stewart CB; Ledingham D; Foster VK; Anderson KN; Sathyanarayana S; Galley D; Pavese N; Pasquini J
    Front Neurol; 2023; 14():1155669. PubMed ID: 37122303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Motor and non-motor features in Parkinson's Disease patients carrying GBA gene mutations.
    De Michele G; Palmieri GR; Pane C; Valente EM; Palmieri I; Dello Iacovo CDP; Cuomo N; Giglio A; De Lucia N; Fico T; Perillo S; De Michele G; De Rosa A
    Acta Neurol Belg; 2023 Feb; 123(1):221-226. PubMed ID: 36609835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The clinical features of Parkinson's disease in patients with mutations and polymorphic variants of GBA gene].
    Senkevich KA; Miliukhina IV; Beletskaia MV; Gracheva EV; Kudrevatykh AV; Nikolaev MA; Emelyanov AK; Kopytova AE; Timofeeva AA; Yakimovskii AF; Pchelina SN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(10):81-86. PubMed ID: 29171494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Features of
    Malek N; Weil RS; Bresner C; Lawton MA; Grosset KA; Tan M; Bajaj N; Barker RA; Burn DJ; Foltynie T; Hardy J; Wood NW; Ben-Shlomo Y; Williams NW; Grosset DG; Morris HR;
    J Neurol Neurosurg Psychiatry; 2018 Jul; 89(7):702-709. PubMed ID: 29378790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Free-Water Imaging of the Substantia Nigra in GBA Pathogenic Variant Carriers.
    Zhang D; Shi Y; Yao J; Zhou L; Wei H; Liu J; Tong Q; Ma L; He H; Wu T
    Mov Disord; 2023 May; 38(5):764-773. PubMed ID: 36797645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of GBA Genotype With Motor and Functional Decline in Patients With Newly Diagnosed Parkinson Disease.
    Maple-Grødem J; Dalen I; Tysnes OB; Macleod AD; Forsgren L; Counsell CE; Alves G
    Neurology; 2021 Feb; 96(7):e1036-e1044. PubMed ID: 33443131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GBA Variants Influence Motor and Non-Motor Features of Parkinson's Disease.
    Jesús S; Huertas I; Bernal-Bernal I; Bonilla-Toribio M; Cáceres-Redondo MT; Vargas-González L; Gómez-Llamas M; Carrillo F; Calderón E; Carballo M; Gómez-Garre P; Mir P
    PLoS One; 2016; 11(12):e0167749. PubMed ID: 28030538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucocerebrosidase mutations influence the natural history of Parkinson's disease in a community-based incident cohort.
    Winder-Rhodes SE; Evans JR; Ban M; Mason SL; Williams-Gray CH; Foltynie T; Duran R; Mencacci NE; Sawcer SJ; Barker RA
    Brain; 2013 Feb; 136(Pt 2):392-9. PubMed ID: 23413260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apathy: An underestimated feature in GBA and LRRK2 non-manifesting mutation carriers.
    Pachi I; Koros C; Simitsi AM; Papadimitriou D; Bougea A; Prentakis A; Papagiannakis N; Bozi M; Antonelou R; Angelopoulou E; Beratis I; Stamelou M; Trapali XG; Papageorgiou SG; Stefanis L
    Parkinsonism Relat Disord; 2021 Oct; 91():1-8. PubMed ID: 34425330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postural instability and gait are associated with severity and prognosis of Parkinson disease.
    van der Heeden JF; Marinus J; Martinez-Martin P; Rodriguez-Blazquez C; Geraedts VJ; van Hilten JJ
    Neurology; 2016 Jun; 86(24):2243-50. PubMed ID: 27178702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of pre-diagnostic symptoms did not differ between LRRK2-related, GBA-related and idiopathic patients with Parkinson's disease.
    Liu SY; Zheng Z; Gu ZQ; Wang CD; Tang BS; Xu YM; Ma JH; Zhou YT; Feng T; Chen SD; Chan P;
    Parkinsonism Relat Disord; 2018 Dec; 57():72-76. PubMed ID: 30119933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of
    Ren J; Zhou G; Wang Y; Zhang R; Guo Z; Zhou H; Zheng H; Sun Y; Ma C; Lu M; Liu W
    Front Aging Neurosci; 2023; 15():1091919. PubMed ID: 36845659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal Measurements of Glucocerebrosidase activity in Parkinson's patients.
    Alcalay RN; Wolf P; Chiang MSR; Helesicova K; Zhang XK; Merchant K; Hutten SJ; Scherzer C; Caspell-Garcia C; Blauwendraat C; Foroud T; Nudelman K; Gan-Or Z; Simuni T; Chahine LM; Levy O; Zheng D; Li G; Sardi SP;
    Ann Clin Transl Neurol; 2020 Oct; 7(10):1816-1830. PubMed ID: 32888397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolution of prodromal parkinsonian features in a cohort of
    Avenali M; Toffoli M; Mullin S; McNeil A; Hughes DA; Mehta A; Blandini F; Schapira AHV
    J Neurol Neurosurg Psychiatry; 2019 Oct; 90(10):1091-1097. PubMed ID: 31221723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical prediction of
    Greenberg J; Astudillo K; Frucht SJ; Flinker A; Riboldi GM
    Clin Park Relat Disord; 2024; 10():100251. PubMed ID: 38645305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.